News & Publications

From April 2026, the MRC Clinical Trials Unit will become the UCL Innovative Clinical Trials Unit. The MRC Clinical Trials Unit has received underpinning funding from the MRC since 1998. This has allowed the Unit to carry out innovative and challenging trials, meta-analyses and methodology research that have had a global impact. This funding will end in March 2026, due to chan ...

*UPDATE* The EJS ACT-PD Registration of Interest links are functional   We have been made aware that the current EJS ACT-PD Registration of Interest links are not working due to a recent update to REDCap. The ROI team are currently investigating this. In the meantime, if you have any patients that are trying to register their interest for EJS ACT-PD, please provide them with ...

The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched in the UK. The Edmond J Safra Accelerating Clinical Trials in Parkinson’s Disease (EJS ACT-PD) trial will test multiple treatments in parallel, accelerating the search for effective treatments by testing more drugs faster and more efficiently than ever befor ...

EJS ACT-PD has now received the approvals needed for the trial to proceed.  These are from the Health Research Authority (HRA), Medicines and Healthcare products Regulatory Agency (MHRA) and the Research Ethics Committee (REC). The next steps are now to work with the selected sites to obtain their local approvals and train them on the trial processes. It is aimed that participa ...